Video

Testosterone therapy does not appear to worsen outcomes in men with COVID-19

Author(s):

Urology Times staff

Amarnath Rambhatla, MD, discusses findings from a study published online in the Journal of Sexual Medicine.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this interview, Amarnath Rambhatla, MD, discusses findings from the Journal of Sexual Medicine study, COVID-19 infection in men on testosterone therapy, for which he served as a study author. Rambhatla is director of men’s health at the Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan.

      More videos:

      Setting expectations in patients with prostate cancer receiving HIFU​

      HIFU for prostate cancer: How it works, criteria for treatment, and contraindications​

      Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing​

      Related Videos
      Experts consider efficacy of fertility restoration vs sperm cryopreservation
      Experts consider efficacy of fertility restoration vs sperm cryopreservation
      Matthew Mutter, MD, shares data on Separo vessel sealing system for vasectomy
      Matthew Mutter, MD, shares data on Separo vessel sealing system for vasectomy
      Fertility restoration may offer benefits in cost, efficacy vs sperm cryopreservation
      Fertility restoration may offer benefits in cost, efficacy vs sperm cryopreservation
      Investigators discuss cost-effectiveness study of cryopreservation vs vasectomy reversal
      Investigators discuss cost-effectiveness study of cryopreservation vs vasectomy reversal
      Justin Dubin, MD, answers a question during a video interview
      Justin Dubin, MD, on potential health effects of SARMs and anabolic steroids
      Man talking with a doctor | Image Credit: © RFBSIP - stock.adobe.com
      Study identifies trends in testosterone use in young adult men
      Kristy L. Mardis, NP, on APP development initiatives in sexual medicine
      Kristy L. Mardis, NP, on APP development initiatives in sexual medicine
      Dr. Nam on potential future research on vasectomy in the post-Dobbs era
      Dr. Nam on potential future research on vasectomy in the post-Dobbs era
      Dr. Nam on the increased interest in vasectomy amidst urologist shortages
      Dr. Nam on the increased interest in vasectomy amidst urologist shortages
      Dr. Rust recaps the SMSNA Men’s Health Fellowship Bootcamp
      Dr. Rust recaps the SMSNA Men’s Health Fellowship Bootcamp
      Related Content
      Label change for testosterone: Implications for urologists, prescribers, and patients
      April 9th 2025

      Label change for testosterone: Implications for urologists, prescribers, and patients

      Hannah Clarke
      In February 2025, the FDA recommended a removal of the black box warning related to an increased risk of adverse cardiovascular outcomes for all testosterone products. This recommendation has important implications for urologists and the patients they treat.
      The urologist's role in dispelling men's health myths
      May 10th 2022

      The urologist's role in dispelling men's health myths

      Urology Times staff
      “I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.
      FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies
      March 3rd 2025

      FDA issues labeling changes for testosterone products following TRAVERSE, postmarket studies

      Hannah Clarke
      The FDA is requiring a warning about increased blood pressure and is recommending that the black box warning related to the increased risk of adverse cardiovascular events be removed.
      Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes
      March 7th 2022

      Destigmatizing Urology: Dr. Espinosa discusses lifestyle changes

      Urology Times staff
      “I think that the audience should know that there is a movement going on,” says Geo Espinosa, ND.
      FDA market clearance sought for Separo sealing system for vasectomy
      January 29th 2025

      FDA market clearance sought for Separo sealing system for vasectomy

      Matthew J. Mutter, MD
      "The biggest thing that I took away from using the device is that it allowed me to do the procedure by myself, without an assistant," says Matthew J. Mutter, MD.
      FDA clears chemiluminescence-based immunoassay for free testosterone
      January 10th 2025

      FDA clears chemiluminescence-based immunoassay for free testosterone

      Hannah Clarke
      The test can provide results in 48 minutes for diagnostic insights for conditions such as hypogonadism, impotence, polycystic ovarian syndrome, and other androgenital syndromes.
      © 2025 MJH Life Sciences

      All rights reserved.